Phase III randomized clinical trial of BV‐4051, an Ayurvedic polyherbal formulation in moderate SARS‐CoV‐2 infections and its impact on inflammatory biomarkers
… (systolic blood pressure > 140 mmHg or diastolic blood pressure>90mmHg), diabetes, … The SOC treatment was per Investigator's discretion following the applicable Indian Council …..... Read More